Virtus ETF Advisers LLC Gh Research PLC Transaction History

Virtus ETF Advisers LLC

  • $206 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$10.15 - $16.15 $751 - $1,195
74 Added 0.74%
10,026 $117,000
Q2 2022

Aug 12, 2022
BUY
$8.99 - $19.87 $29,352 - $64,875
3,265 Added 48.83%
9,952 $99,000
Q1 2022

May 16, 2022
SELL
$15.48 - $23.98 $6,176 - $9,568
-399 Reduced 5.63%
6,687 $122,000
Q4 2021

Feb 14, 2022
BUY
$14.1 - $27.9 $99,912 - $197,699
7,086 New
7,086 $165,000

Others Institutions Holding GHRS

# of Institutions
32
Shares Held
27.8M
Call Options Held
2.8K
Put Options Held
3.8K
View Full List

About GH Research PLC

GHRS Quotes by TradingView
  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $369M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email